English
  1. Home
  2. Stocks
  3. Solara Share Price
  • Chart
  • Financials
  • Technicals
  • Volume
  • Result
  • Synopsis
  • Corp Action
  • MF Shareholding
  • Similar Stocks
  • FAQs

    • Solara Active Pharma Sciences Share Price Solara Active Pharma Sciences

    Small Cap
    ₹492.35
    -3.1 (-0.63%)
    13 May, 2024 05:48 BSE: 541540 NSE: SOLARAISIN: INE624Z01016

    Start SIP in Solara Active Pharma Sciences

    Start SIP

    Solara Active Pharma Sciences Performance

    Day Range

    • Low 464
    • High 498
    ₹ 492

    52 Week Range

    • Low 286
    • High 606
    ₹ 492
    • Open Price495
    • Previous Close495
    • Volume438630

    Solara Active Pharma Sciences Share Price

    • Over 1 Month +17.49%
    • Over 3 Month +26.73%
    • Over 6 Month +50.04%
    • Over 1 Year +19.4%

    Solara Active Pharma Sciences Key Statistics

    P/E Ratio -5.7
    PEG Ratio 0
    Market Cap Cr 1,772
    Price to Book Ratio 1.2
    EPS -6
    Dividend 0
    Relative Strength Index 50.45
    Money Flow Index 65.13
    MACD Signal 28.31
    Average True Range 31.53
    Solara Active Pharma Sciences Financials
    IndicatorDec 2023Sep 2023Jun 2023Mar 2023
    Oper Rev Qtr Cr 249425352381
    Operating Expenses Qtr Cr 410388333329
    Operating Profit Qtr Cr -162381952
    Depreciation Qtr Cr 26262626
    Interest Qtr Cr 25242622
    Tax Qtr Cr 00-102
    Net Profit Qtr Cr -275-15-206
    Sign Up to Know More
    IndicatorMar 2023
    Total Revenue Annual Cr 1,466
    Operating Expenses Annual Cr 1,310
    Operating Profit Annual in Cr 134
    Depreciation Cr 111
    Interest Annual Cr 90
    Tax Annual Cr -23
    Net Profit Annual Cr -22
    Sign Up to Know More
    IndicatorMar 2023
    Cash from Operating Activity Annual Cr 156
    Cash from Investing Activity Annual Cr -81
    Cash from Financing Annual Activity Cr -113
    Net Cash Flow Annual Cr -38
    Sign Up to Know More
    IndicatorMar 2023
    Total ShareHolders Funds Annual Cr 1,503
    Fixed Assets Annual Cr 1,580
    Total Non Current Assets Annual Cr 1,704
    Total Current Assets Annual Cr 1,191
    Total Assets Annual Cr 2,895
    Sign Up to Know More
    IndicatorMar 2023
    Book Value Per Share Annual Rs 418
    ROE Annual % -1
    ROCE Annual % 3
    Total Debt to Total Equity Annual -
    EBDIT Annual Margin % 11
    Sign Up to Know More
    IndicatorDec 2023Sep 2023Jun 2023Mar 2023
    Oper Rev Qtr Cr 249425352381
    Operating Expenses Qtr Cr 410388333332
    Operating Profit Qtr Cr -162381949
    Depreciation Qtr Cr 26262626
    Interest Qtr Cr 25242522
    Tax Qtr Cr 00-101
    Net Profit Qtr Cr -275-17-204
    Sign Up to Know More
    IndicatorMar 2023
    Total Revenue Annual Cr 1,466
    Operating Expenses Annual Cr 1,310
    Operating Profit Annual in Cr 134
    Depreciation Cr 111
    Interest Annual Cr 90
    Tax Annual Cr -23
    Net Profit Annual Cr -22
    Sign Up to Know More
    IndicatorMar 2023
    Cash from Operating Activity Annual Cr 156
    Cash from Investing Activity Annual Cr -81
    Cash from Financing Annual Activity Cr -113
    Net Cash Flow Annual Cr -38
    Sign Up to Know More
    IndicatorMar 2023
    Total ShareHolders Funds Annual Cr 1,500
    Fixed Assets Annual Cr 1,237
    Total Non Current Assets Annual Cr 1,712
    Total Current Assets Annual Cr 1,188
    Total Assets Annual Cr 2,899
    Sign Up to Know More
    IndicatorMar 2023
    Book Value Per Share Annual Rs 417
    ROE Annual % -1
    ROCE Annual % 3
    Total Debt to Total Equity Annual -
    EBDIT Annual Margin % 11
    Sign Up to Know More
    Invest in Solara Active Pharma Sciences

    Solara Active Pharma Sciences Technicals

    EMA & SMA

    Current Price
    ₹492.35
    -3.1 (-0.63%)
    pointer
    • Bullish Moving Average
    • ___
    • 9
    • Bearish Moving Average
    • ___
    • 7
    • 20 Day
    • ₹501.45
    • 50 Day
    • ₹464.14
    • 100 Day
    • ₹432.58
    • 200 Day
    • ₹411.86
    • 20 Day
    • ₹507.58
    • 50 Day
    • ₹450.22
    • 100 Day
    • ₹422.57
    • 200 Day
    • ₹387.97

    Solara Active Pharma Sciences Resistance and Support

    PIVOT
    ₹484.75
    Resistance
    First Resistance 505.50
    Second Resistance 518.65
    Third Resistance 539.40
    RSI 50.45
    MFI 65.13
    MACD Single Line 28.31
    MACD 20.45
    Support
    First Resistance 471.60
    Second Resistance 450.85
    Third Resistance 437.70

    Solara Active Pharma Sciences Delivery and Volume

    Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
    Day 501,545 19,720,749 39.32
    Week 315,222 13,472,588 42.74
    1 Month 1,093,274 21,887,336 20.02
    6 Month 492,045 15,637,205 31.78

    Solara Active Pharma Sciences Result Highlights

    Solara Active Pharma Sciences Synopsis

    NSE-Medical-Diversified

    Solara Active Pharma is involved in the business activities of Manufacture of medicinal substances used in the manufacture of pharmaceuticals: antibiotics, endocrine products, basic vitamins; opium derivatives; sulpha drugs; serums and plasmas; salicylic acid, its salts and esters; glycosides and vegetable alkaloids; chemically pure suger etc.. Company’s Total Operating Revenue is Rs. 1443.81 Cr. and Equity Capital is Rs. 36.00 Cr. for the Year ended 31/03/2023. Solara Active Pharma Sciences Ltd. is a Public Limited Listed company incorporated on 23/02/2017 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L24230MH2017PLC291636 and registration number is 291636.
    Market Cap 1,772
    Sales 1,407
    Shares in Float 2.52
    No of funds 47
    Yield
    Book Value 1.18
    U/D Vol ratio 3.5
    LTDebt / Equity 16
    Alpha 0.04
    Beta 1.36

    Solara Active Pharma Sciences

    Owner NameMar-24Dec-23Sep-23Jun-23
    Promoters 30.49%30.49%37.19%39.31%
    Mutual Funds 1.71%1.71%1.75%1.71%
    Foreign Portfolio Investors 15.8%16.62%17.86%18.71%
    Financial Institutions/ Banks 0.04%0.04%
    Individual Investors 20.15%20.96%19.84%18.06%
    Others 31.81%30.22%23.32%22.21%

    Solara Active Pharma Sciences Management

    Name Designation
    Mr. Poorvank Purohit Managing Director & CEO
    Mr. Kartheek Chintalapati Raju Non Executive Director
    Mr. Ankur Nand Thadani Non Executive Director
    Mr. Arun Kumar Non Executive Director
    Mr. R Ramakrishnan Independent Director
    Dr. Kausalya Santhanam Independent Director

    Solara Active Pharma Sciences Forecast

    Price Estimates

    2,000(9.8%)
    1,758(-3.5%)
    1,590(-12.7%)

    Other Analyst Rating

    Solara Active Pharma Sciences Corporate Action

    Date Purpose Remarks
    2024-05-09 To consider Fund Raising
    2024-02-14 Quarterly Results
    2023-11-14 Quarterly Results
    2023-08-14 Quarterly Results (Revised) per share(50%)Final Dividend
    2023-07-05 Right issue of Equity Shares

    Solara Active Pharma Sciences MF Shareholding

    Name Amount(cr)
    Aditya Birla Sun Life Flexi Cap Fund Growth 19,967
    Aditya Birla Sun Life Mid Cap Fund Growth 4,913
    Aditya Birla Sun Life Manufacturing Equity Fund Regular Plan Growth 873

    Solara Active Pharma Sciences FAQs

    What is Share Price of Solara Active Pharma Sciences ?

    Solara Active Pharma Sciences share price is ₹492 As on 13 May, 2024 | 05:34

    What is the Market Cap of Solara Active Pharma Sciences ?

    The Market Cap of Solara Active Pharma Sciences is ₹1772.3 Cr As on 13 May, 2024 | 05:34

    What is the P/E ratio of Solara Active Pharma Sciences ?

    The P/E ratio of Solara Active Pharma Sciences is -5.7 As on 13 May, 2024 | 05:34

    What is the PB ratio of Solara Active Pharma Sciences ?

    The PB ratio of Solara Active Pharma Sciences is 1.2 As on 13 May, 2024 | 05:34

    Q2FY23

    More Information

    CIN: L67190MH2007PLC289249 | Stock Broker SEBI Regn.: INZ000010231 | SEBI RA Regn.: INH000004680 | SEBI Depository Regn.: IN DP CDSL: IN-DP-192-2016 | AMFI REGN No.: ARN-104096 | NSE Member id: 14300 | BSE Member id: 6363 | MCX Member ID: 55945 | Investment Adviser Regn No: INA000014252 | Registered Address - IIFL House, Sun Infotech Park, Road no. 16V, Plot no. B-23, MIDC, Thane Industrial Area, Waghle Estate, Thane, Maharashtra - 400604

    *Brokerage will be levied flat fee/executed order basis and not on a percentage basis. Flat fee of Rs. 10/order is available with Power Investor & Ultra Trader Packs. Investment in securities market are subject to market risk, read all related documents carefully before investing. Digital account would be opened after all procedure relating to IPV and client due diligence is completed. If sale/ purchase value of share of Rs.10/- or less, a maximum brokerage of 25 paisa per share may be collected. Brokerage will not exceed the SEBI prescribed limit.

    Compliance Officer: Ms. Namita Godbole, Email: support@5paisa.com, Support Desk Helpline: 8976689766

    Contact Us

    Attention Investors

    • 1. No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.
    • 2. Message from Exchange(s): Prevent Unauthorised transactions in your account --> Update your mobile numbers/email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day. Issued in the interest of investors.
    • 3. Message from Depositories: a) Prevent Unauthorized Transactions in your demat account --> Update your mobile number with your Depository Participant. Receive alerts on your registered mobile for all debit and other important transactions in your demat account directly from CDSL on the same day issued in the interest of investors. b) KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.

    Email: support@5paisa.com

    Support Desk Helpline: 8976689766

    ©2024, 5Paisa Capital Ltd. All Rights Reserved. We are ISO 27001:2013 Certified.